These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29853942)

  • 21. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S; Luo C; Zhou K; Hua Y; Wu M; Liu L; Liu X; Wang C
    Pediatr Rheumatol Online J; 2019 Sep; 17(1):65. PubMed ID: 31533770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
    Kato M; Ayusawa M; Watanabe H; Komori A; Abe Y; Nakamura T; Kamiyama H; Takahashi S
    Pediatr Int; 2018 Apr; 60(4):342-348. PubMed ID: 29350882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Terminal Pro-Brain Natriuretic Peptide Levels in Kawasaki Disease, Sepsis and Other Febrile Illnesses.
    Banerjee P; Pal P; Chakravarti S; Basu S; Ahmed N
    Indian Pediatr; 2023 Oct; 60(10):826-828. PubMed ID: 37551875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of age-adjusted N-terminal prohormone of brain natriuretic peptide level as a diagnostic marker for incomplete Kawasaki disease in children.
    Rodríguez-González M; Castellano-Martínez A; Alonso-Ojembarrena A
    Emergencias; 2019 Abr; 31(2):111-114. PubMed ID: 30963739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L; Dionne A; Meloche-Dumas L; Fournier A; Dahdah N
    Pediatr Cardiol; 2020 Jun; 41(5):947-954. PubMed ID: 32172336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Detection of Kawasaki Disease in Infants.
    Kang JH; Hong SJ; Seo IA; Kwak MH; Cho SM; Kim DK; Choi SM; Lee DS
    Korean Circ J; 2015 Nov; 45(6):510-5. PubMed ID: 26617654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review.
    Jiang H; Yang Z
    Front Pediatr; 2020; 8():93. PubMed ID: 32211357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of color Doppler echocardiography combined with clinical markers in diagnosis and prediction of prognosis of coronary artery lesions in Kawasaki disease.
    Xue M; Wang J
    Exp Ther Med; 2020 Apr; 19(4):2597-2603. PubMed ID: 32256739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014.
    Kim MK; Song MS; Kim GB
    Korean Circ J; 2018 Jan; 48(1):71-79. PubMed ID: 29171205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A child with Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis complicated by coronary artery lesion mimicking Kawasaki disease.
    Kato S; Yoshimura K; Tanabe Y; Kimata T; Noda Y; Kawasaki H; Kaneko K
    J Pediatr Hematol Oncol; 2013 Oct; 35(7):e317-9. PubMed ID: 23619112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis.
    Titze U; Janka G; Schneider EM; Prall F; Haffner D; Classen CF
    Pediatr Blood Cancer; 2009 Sep; 53(3):493-5. PubMed ID: 19434728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
    McNeal-Davidson A; Fournier A; Spigelblatt L; Saint-Cyr C; Mir TS; Nir A; Dallaire F; Cousineau J; Delvin E; Dahdah N
    Pediatr Int; 2012 Oct; 54(5):627-33. PubMed ID: 22414326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
    Kim SY; Han MY; Cha SH; Jeon YB
    Pediatr Cardiol; 2013; 34(8):1837-43. PubMed ID: 23744100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study.
    Mottaghipisheh H; Kalantar K; Amanati A; Shokripour M; Shahriari M; Zekavat OR; Zareifar S; Karimi M; Haghpanah S; Bordbar M
    BMC Infect Dis; 2021 Aug; 21(1):732. PubMed ID: 34340686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
    Cho SY; Kim Y; Cha SH; Suh JT; Han MY; Lee HJ
    Ann Clin Lab Sci; 2011; 41(4):360-3. PubMed ID: 22166506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
    Iwashima S; Ishikawa T
    World J Pediatr; 2013 Aug; 9(3):239-44. PubMed ID: 23335186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.